ASXL1 mutations are associated with distinctive epigenomic alterations that bring about sensitivity to venetoclax and azacytidine Desk one (fifteen–85) summarizes genes with diminished expression in most cancers for a consequence of hypermethylation in their promoter regions. The absence or reduction in the protein functionality connected with these genes is implicated https://annev940bew5.wikinarration.com/user